Programmable CRISPR platform can reduce stem cell differentiation from months to weeks
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in Science Advances detailing the company’s CRISPR-based Cellgorithm technology, which lays the groundwork for programmable control of gene […]
